(Q40569388)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

title

Drug-induced lupus following treatment with infliximab in rheumatoid arthritis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

Massimo Varenna

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

author name string

L Sinigaglia

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

C Arnoldi

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

publication date

1 January 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

issue

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

page(s)

753-755

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

Repeated therapy with monoclonal antibody to tumour necrosis factor alpha (cA2) in patients with rheumatoid arthritis

15 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU236CR

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU236CR

Assessment of antibodies to double-stranded DNA induced in rheumatoid arthritis patients following treatment with infliximab, a monoclonal antibody to tumor necrosis factor alpha: findings in open-label and randomized placebo-controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU236CR

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU236CR

Serologic Evaluation of Patients Receiving Procainamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1191%2F0961203302LU236CR

10.1191/0961203302LU236CR

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12475006%20AND%20SRC:MED&resulttype=core&format=json

15 December 2019

1 reference